Skip to content

Study of Lung Cancer in Appalachian Kentucky: The Role of Environmental Carcinogens

A Population-based Case-control Study of Lung Cancer in Appalachian Kentucky: The Role of Environmental Carcinogens

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01648166
Enrollment
520
Registered
2012-07-24
Start date
2011-09-30
Completion date
2019-09-04
Last updated
2019-11-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung Cancer

Keywords

trace, element, lung, cancer, Appalachia

Brief summary

This is a research study about the relationship between lung cancer and environmental risk factors. The purpose of this study is to try to understand the effects of trace elements such as arsenic and chromium, as well as radon on the development of lung cancer. To do this, the investigators will collect information and environmental and biologic specimens from people who live in Appalachian Kentucky who a) have lung cancer or b) don't have lung cancer and will serve as control subjects. The investigators will create a specimen repository of from these people and their residences to compare differences in many risks factors for cancer. By doing this study, the investigators hope to learn why there are more lung cancers in Kentucky's fifth Congressional District than anywhere else in the nation.

Detailed description

Appalachian Kentucky has one of the highest incidence rates of lung cancer in the United States. The disproportionately high incidence is not explained by tobacco alone. Preliminary analysis of trace element content in toenail samples reveals higher levels of arsenic, chromium and nickel in Appalachian Kentucky residents than elsewhere in Kentucky. Trace elements are known to promote carcinogenesis by increased oxidative stress, inflammation, DNA damage, and reduced DNA repair efficiency. These findings justify further investigation of the role that trace elements play in the development of lung cancer in this region. Hypothesis: The unexpectedly high rate of lung cancer in Appalachian Kentucky is associated with exposure to environmental carcinogens that increase oxidative stress and DNA damage. Specific Aims Aim 1: Conduct a case-control study of lung cancer and matched controls in the 5th Congressional District of Kentucky to compare rates of moderate to high arsenic in lung cancer cases and controls. Aim 2: Create a specimen repository of biologic and environmental samples from these subjects and their residences for analysis of DNA repair markers and, in the future, markers of oxidative stress and inflammation. Aim 3: Fund four pilot projects which will utilize collected data from Aim 1 to develop investigators focused on lung cancer research in this study population and to generate preliminary data that will lead to independent funding. Study Design: This is a population-based, case-control study encompassing the 5th Congressional District of Kentucky. Relevance: This translational research and repository will fundamentally improve our understanding of the causes of the disproportionately high incidence of lung cancer in Appalachian Kentucky, foster collaboration among scientists dedicated to the study of lung cancer and provide a permanent resource to be used for future research.

Interventions

Soil, water, blood, urine, hair and radon testing in homes in Appalachia

Sponsors

United States Department of Defense
CollaboratorFED
Susanne Arnold
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

The following eligibility criteria are required for study entry and participation. Inclusion (Lung cancer cases): * Living persons with histologically or cytologically confirmed primary carcinoma of the lung (International Classification of Diseases-9, 162.2-162.9) between October 17, 2011 and October 16, 2013 * Age greater than 17 * Must be residents of the 5th Congressional District * No prior history of any cancer (other than stage I and II non-melanomatous skin cancer) * Must have a working phone * Ability to participate in an in-person interview * English speaking will be eligible for the study (no proxy respondents will be used) Inclusion (Control cases): * Age greater than 17 * No prior history of any cancer (other than stage I and II non-melanomatous skin cancer) * Must be residents of the 5th Congressional District at the time they are matched to the case. * Must have a working phone * Ability to participate in an in-person interview * English speaking will be eligible for the study (no proxy respondents will be used) Exclusion: * History of any cancers other than those listed above * Non-residents of the 5th congressional district of Kentucky * Age 17 years or less

Design outcomes

Primary

MeasureTime frameDescription
Rate of Moderate to High Arsenic Level in Cases and Controlsup to three yearsConduct a case-control study of lung cancer and matched controls in the 5th Congressional District of Kentucky to compare rates of moderate to high arsenic in lung cancer cases and controls (primary endpoint).

Countries

United States

Participant flow

Participants by arm

ArmCount
Lung Cancer Cases
subjects with lung cancer who are greater than 17 years of age and live in Appalachian Kentucky Environmental sampling: Soil, water, blood, urine, hair and radon testing in homes in Appalachia
100
Control Subjects
subjects without lung cancer, greater than 17 who reside in Appalachian Kentucky Environmental sampling: Soil, water, blood, urine, hair and radon testing in homes in Appalachia
267
Total367

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall Studyinadequate toenail samples53100

Baseline characteristics

CharacteristicLung Cancer CasesControl SubjectsTotal
Age, Continuous62 years62 years62 years
Region of Enrollment
United States
100 participants267 participants367 participants
Sex: Female, Male
Female
61 Participants148 Participants209 Participants
Sex: Female, Male
Male
39 Participants119 Participants158 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 1000 / 267
serious
Total, serious adverse events
0 / 1000 / 267

Outcome results

Primary

Rate of Moderate to High Arsenic Level in Cases and Controls

Conduct a case-control study of lung cancer and matched controls in the 5th Congressional District of Kentucky to compare rates of moderate to high arsenic in lung cancer cases and controls (primary endpoint).

Time frame: up to three years

Population: those with adequate toenail arsenic concentrations

ArmMeasureValue (MEDIAN)
Lung Cancer CasesRate of Moderate to High Arsenic Level in Cases and Controls0.04 mcg/dL
Control SubjectsRate of Moderate to High Arsenic Level in Cases and Controls0.04 mcg/dL

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026